Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 964 (LINC00964) is a member of the long non-coding RNA (lncRNA) class, specifically an intergenic transcript that does not encode proteins. LncRNAs, such as those in the LINC family, are typically involved in regulating gene expression at both the transcriptional and post-transcriptional level, often through chromatin modification, transcriptional interference, or serving as competing endogenous RNAs (ceRNAs) to modulate microRNA activity[3]. There is minimal specific research characterizing the biological function, disease relevance, or therapeutic tractability of LINC00964 itself. No data currently support its use as a clinical biomarker, disease-associated gene, or direct therapeutic target. If you require information about similar lncRNAs with established disease relevance or drug interactions (e.g., LINC00467, LINC00641) those are available in the literature[1][3], but LINC00964 itself lacks detailed experimental or clinical characterization at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 964 (LINC00964).